Table 2.
The most significant SNPs associated with SSC resistance identified in this study
| Marker ID | Chrom. | Pos (bp) | MAF | p.value | r 2 | FDR Adjusted p-values |
|---|---|---|---|---|---|---|
| GBSRdm370 | 14 | 1,744,370 | 0.30 | 1.93E-31 | 0.70 | 6.35E-27 |
| GBSRdm556 | 14 | 1,725,556 | 0.24 | 2.97E-28 | 0.64 | 4.88E-24 |
| GBSRdm287 | 14 | 1,710,287 | 0.28 | 5.61E-28 | 0.63 | 5.66E-24 |
| GBSRdm224 | 14 | 1,986,224 | 0.27 | 6.89E-28 | 0.63 | 5.66E-24 |
| GBSRdm562 | 14 | 1,740,562 | 0.25 | 2.87E-27 | 0.62 | 1.89E-23 |
| GBSRdm793 | 14 | 1,768,793 | 0.42 | 3.66E-25 | 0.59 | 2.00E-21 |
| GBSRdm339 | 14 | 1,921,339 | 0.28 | 4.17E-22 | 0.54 | 1.71E-18 |
| GBSRdm374 | 14 | 1,921,374 | 0.28 | 4.17E-22 | 0.54 | 1.71E-18 |
| GBSRdm219 | 14 | 1,795,219 | 0.45 | 8.48E-21 | 0.52 | 3.09E-17 |
| GBSRdm204 | 14 | 1,751,204 | 0.21 | 1.60E-19 | 0.50 | 5.27E-16 |
| GBSRdm516 | 14 | 1,612,516 | 0.27 | 2.26E-17 | 0.47 | 6.75E-14 |
| GBSRdm964 | 14 | 1,850,964 | 0.40 | 2.57E-17 | 0.47 | 7.02E-14 |
| GBSRdm114 | 14 | 1,851,114 | 0.40 | 4.80E-17 | 0.46 | 1.21E-13 |
| GBSRdm450 | 14 | 1,612,450 | 0.26 | 9.59E-16 | 0.45 | 2.25E-12 |
| GBSRdm397 | 14 | 1,612,397 | 0.23 | 1.19E-14 | 0.43 | 2.60E-11 |
| GBSRdm518 | 14 | 1,744,518 | 0.46 | 1.52E-14 | 0.43 | 3.13E-11 |
| GBSRdm120 | 14 | 1,741,120 | 0.45 | 4.36E-14 | 0.42 | 8.43E-11 |
| GBSRdm712 | 14 | 1,581,712 | 0.23 | 4.26E-13 | 0.41 | 7.77E-10 |
| GBSRdm875 | 14 | 1,581,875 | 0.32 | 2.39E-12 | 0.40 | 4.13E-09 |
Chrom. Chromosome, Pos (bp) physical position of the allelic variant, MAF Minor allele frequency, r2 R squared value of the model with the SNP. All SNPs were physically positioned in the Wm82.a2 version of the Glycine max genome